A newly discovered function for the ApoE4 gene, the strongest genetic risk factor for Alzheimer’s disease, may help explain how the gene causes cognitive decline.
As the World Cup games continue, we talked to neurologist James Noble, MD, about the known—and unknown—risks of heading in soccer.
In one of the first studies of its kind, Columbia’s Philip De Jager shows how "big data" analyses may lead to new treatment strategies for Alzheimer's disease.
Scientists at Columbia University Vagelos College of Physicians and Surgeons present the most definitive evidence to date that the human brain makes new neurons throughout life.
Columbia neurologist William Kreisl, MD, explains the potential uses—and limitations—of a smell test in sniffing out Alzheimer's disease risk.
On average, patients see more than eight physicians before being diagnosed with a mitochondrial disease, a new CUIMC study finds.